Diabetes
Commentary
Rosiglitazone: Failure of oversight or demons imagined?
Applied Evidence
Using prandial insulin to achieve glycemic control in type 2 diabetes
A stepped approach to postprandial hyperglycemia—including prandial insulin—is key.
Commentary
Is further research needed on glucosamine?
Commentary
Was insulin review biased, or simply a victim of bad timing?
Applied Evidence
Diabetes drug update: How 4 new options stack up
3 new agents and a new delivery system for insulin.
Clinical Inquiries
Angiotensin blockade for diabetes: Monitor microalbuminuria?
EVIDENCE-BASED ANSWER: No studies address whether continued screening for microalbuminuria once a patient is taking an angiotensin-converting...
Clinical Inquiries
Do glucosamine and chondroitin worsen blood sugar control in diabetes?
EVIDENCE-BASED ANSWER: Despite theoretical risks based on animal models given high intravenous doses, glucosamine/chondroitin (1500 mg/1200 mg...
Clinical Inquiries
What is the best medical therapy for new-onset type 2 diabetes?
EVIDENCE-BASED ANSWER: Sulfonylureas, metformin, thiazolidinediones, and non-sulfonylurea secretagogues differ little in their ability to decrease...
Clinical Inquiries
What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?
EVIDENCE-BASED ANSWER: Combination therapy using insulin plus metformin (Glucophage), a sulfonylurea, or both produces glycemic control comparable...